| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 246
Authors: 958,
Journals: 112,
Outer References: 9412
Collection span: 2002 - 2004
View: Overview. Sorted by year, source, volume, issue, page.
Page 2: 1 (1) 2 (101) 3 (201)
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 101 | 1 | 56 | 101 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(49):48644-48650 Devlin GL; Carver JA; Bottomley SP The selective inhibition of serpin aggregation by the molecular chaperone, alpha-crystallin, indicates a nucleation-dependent specificity | 0 | 1 |
| 102 | 1 | 42 | 102 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(51):51035-51043 Chyung JH; Selkoe DJ Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface | 0 | 1 |
| 103 | 2 | 47 | 103 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(51):51770-51778 Laurine E; Gregoire C; Fandrich M; Engemann S; Marchal S; Thion L; Mohr M; Monsarrat B; Michel B; Dobson CM; Wanker E; Erard M; Verdier JM Lithostathine quadruple-helical filaments form proteinase K-resistant deposits in Creutzfeldt-Jakob disease | 1 | 1 |
| 104 | 3 | 34 | 104 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(52):52519-52523 Capell A; Kaether C; Edbauer D; Shirotani K; Merkl S; Steiner H; Haass C Nicastrin interacts with gamma-secretase complex components via the N-terminal part of its transmembrane domain | 0 | 2 |
| 105 | 1 | 61 | 105 2003 JOURNAL OF COMPARATIVE NEUROLOGY 462(4):371-381 German DC; Yazdani U; Speciale SG; Pasbakish P; Games D; Liang CL Cholinergic neuropathology in a mouse model of Alzheimer's disease | 0 | 4 |
| 106 | 2 | 74 | 106 2003 JOURNAL OF LIPID RESEARCH 44(8):1423-1430 Raffai RL; Weisgraber KH Cholesterol: from heart attacks to Alzheimer's disease | 0 | 4 |
| 107 | 1 | 47 | 107 2003 JOURNAL OF MOLECULAR BIOLOGY 325(4):743-757 Gorman PM; Yip CM; Fraser PE; Chakrabartty A Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: A beta association kinetics at endosomal pH | 1 | 10 |
| 108 | 5 | 63 | 108 2003 JOURNAL OF MOLECULAR BIOLOGY 332(4):795-808 Lashuel HA; Hartley DM; Petre BM; Wall JS; Simon MN; Walz T; Lansbury PT Mixtures of wild-type and a pathogenic (E22G) form of A beta 40 in vitro accumulate protofibrils, including amyloid pores | 4 | 8 |
| 109 | 11 | 200 | 109 2003 JOURNAL OF MOLECULAR MEDICINE-JMM 81(11):678-699 Stefani M; Dobson CM Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution | 5 | 15 |
| 110 | 2 | 29 | 110 2003 JOURNAL OF MOLECULAR NEUROSCIENCE 20(3):305-313 Chang L; Bakhos L; Wang ZQ; Venton DL; Klein WL Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening | 4 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 111 | 2 | 20 | 111 2003 JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM 666:537-545 Almeida DRP; Gasparro DM; Pisterzi LF; Juhasz JR; Fulop F; Csizmadia IG Predicting the conformations of carvedilol based on its pharmacophore fragments: a gas phase and solvation ab initio and density functional study | 1 | 1 |
| 112 | 1 | 51 | 112 2003 JOURNAL OF NEURAL TRANSMISSION 110(11):1313-1327 Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E The neuroprotective effects of Cerebrolysin (TM) in a transgenic model of Alzheimer's disease are associated with improved behavioral performance | 0 | 0 |
| 113 | 3 | 38 | 113 2003 JOURNAL OF NEUROCHEMISTRY 85(6):1581-1591 Sergeant N; Bombois S; Ghestem A; Drobecq H; Kostanjevecki V; Missiaen C; Wattez A; David JP; Vanmechelen E; Sergheraert C; Delacourte A Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach | 1 | 4 |
| 114 | 1 | 57 | 114 2003 JOURNAL OF NEUROCHEMISTRY 87(3):609-619 Zou K; Kim D; Kakio A; Byun K; Gong JS; Kim J; Kim M; Sawamura N; Nishimoto S; Matsuzaki K; Lee B; Yanagisawa K; Michikawa M Amyloid beta-protein (A beta)1-40 protects neurons from damage induced by A beta 1-42 in culture and in rat brain | 0 | 1 |
| 115 | 2 | 44 | 115 2003 JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 62(12):1220-1227 Jankowsky JL; Xu GL; Fromholt D; Gonzales V; Borchelt DR Environmental enrichment exacerbates amyloid plaque formation in a Transgenic mouse model of Alzheimer disease | 0 | 1 |
| 116 | 1 | 42 | 116 2003 JOURNAL OF NEUROPHYSIOLOGY 89(6):3061-3069 Freir DB; Costello DA; Herron CE A beta(25-35)-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil | 2 | 3 |
| 117 | 1 | 25 | 117 2003 JOURNAL OF NEUROSCIENCE 23(6):1992-1996 Marr RA; Rockenstein E; Mukherjee A; Kindy MS; Hersh LB; Gage FH; Verma IM; Masliah E Neprilysin gene transfer reduces human amyloid pathology in transgenic mice | 1 | 16 |
| 118 | 1 | 42 | 118 2003 JOURNAL OF NEUROSCIENCE 23(12):5219-5226 Dickey CA; Loring JF; Montgomery J; Gordon MN; Eastman PS; Morgan D Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein plus presenilin-1 transgenic mice | 2 | 9 |
| 119 | 3 | 47 | 119 2003 JOURNAL OF NEUROSCIENCE 23(24):8453-8459 Beckmann N; Schuler A; Mueggler T; Meyer EP; Wiederhold KH; Staufenbiel M; Krucker T Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease | 0 | 3 |
| 120 | 2 | 49 | 120 2003 JOURNAL OF NEUROSCIENCE 23(26):8844-8853 Cirrito JR; May PC; O'Dell MA; Taylor JW; Parsadanian M; Cramer JW; Audia JE; Nissen JS; Bales KR; Paul SM; DeMattos RB; Holtzman DM In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life | 0 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 121 | 1 | 15 | 121 2003 JOURNAL OF PHARMACOLOGICAL SCIENCES 91(4):330-333 Takata K; Kitamura Y; Umeki M; Tsuchiya D; Kakimura JI; Taniguchi T; Gebicke-Haerter PJ; Shimohama S Possible involvement of small oligomers of amyloid-beta peptides in 15-deoxy-Delta(12,14) prostaglandin J(2)-sensitive microglial activation | 0 | 1 |
| 122 | 7 | 66 | 122 2003 JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 125(50):15359-15365 Bitan G; Tarus B; Vollers SS; Lashuel HA; Condron MM; Straub JE; Teplow DB A molecular switch in amyloid assembly: Met(35) and amyloid beta-protein oligomerization | 2 | 4 |
| 123 | 2 | 51 | 123 2003 JOURNAL OF VIROLOGY 77(13):7611-7622 Chiesa R; Piccardo P; Quaglio E; Drisaldi B; Si-Hoe SL; Takao M; Ghetti B; Harris DA Molecular distinction between pathogenic and infectious properties of the prion protein | 0 | 4 |
| 124 | 2 | 11 | 124 2003 LANCET NEUROLOGY 2(8):461-462 El-Agnaf OMA; Walsh DM; Allsop D Soluble oligomers for the diagnosis of neurodegenerative diseases | 0 | 0 |
| 125 | 1 | 58 | 125 2003 LANCET NEUROLOGY 2(8):506-511 Silverberg GD; Mayo M; Saul T; Rubenstein E; McGuire D Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis | 1 | 4 |
| 126 | 2 | 217 | 126 2003 MASS SPECTROMETRY REVIEWS 22(1):1-26 Konermann L; Simmons DA Protein-folding kinetics and mechanisms studied by pulse-labeling and mass spectrometry | 0 | 7 |
| 127 | 1 | 95 | 127 2003 MOLECULAR BIOLOGY OF THE CELL 14(11):4541-4556 Ardley HC; Scott GB; Rose SA; Tan NGS; Markham AF; Robinson PA Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin | 1 | 9 |
| 128 | 1 | 240 | 128 2003 MOLECULAR NEUROBIOLOGY 27(3):249-276 Davis S; Laroche S What can rodent models tell us about cognitive decline in Alzheimer's disease? | 0 | 0 |
| 129 | 3 | 45 | 129 2003 MOLECULAR PHARMACOLOGY 64(5):1160-1168 Moss MA; Nichols MR; Reed DK; Hoh JH; Rosenberry TL The peptide KLVFF-K-6 promotes beta-amyloid(1-40) protofibril growth by association but does not alter protofibril effects on cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) | 0 | 1 |
| 130 | 8 | 71 | 130 2003 NATURE 426(6968):884-890 Dobson CM Protein folding and misfolding | 1 | 16 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 131 | 4 | 26 | 131 2003 NATURE 426(6968):900-904 Selkoe DJ Folding proteins in fatal ways | 0 | 9 |
| 132 | 2 | 49 | 132 2003 NATURE 426(6968):905-909 Cohen FE; Kelly JW Therapeutic approaches to protein-misfolding diseases | 1 | 11 |
| 133 | 1 | 15 | 133 2003 NATURE GENETICS 34(2):151-153 Levy-Nissenbaum E; Betz RC; Frydman M; Simon M; Lahat H; Bakhan T; Goldman B; Bygum A; Pierick M; Hillmer AM; Jonca N; Toribio J; Kruse R; Dewald G; Cichon S; Kubisch C; Guerrin M; Serre G; Nothen MM; Pras E Hypotrichosis simplex of the scalp is associated with nonsense mutations in CDSN encoding corneodesmosin | 0 | 6 |
| 134 | 1 | 13 | 134 2003 NATURE NEUROSCIENCE 6(4):328-330 Carlson GA A welcoming environment for amyloid plaques | 0 | 1 |
| 135 | 2 | 148 | 135 2003 NATURE REVIEWS NEUROSCIENCE 4(1):49-60 Soto C Unfolding the role of protein misfolding in neurodegenerative diseases | 3 | 42 |
| 136 | 1 | 51 | 136 2003 NEUROBIOLOGY OF AGING 24(3):415-420 Drake J; Link CD; Butterfield DA Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model | 4 | 12 |
| 137 | 1 | 37 | 137 2003 NEUROBIOLOGY OF DISEASE 13(3):177-190 Ye CP; Selkoe DJ; Hartley DM Protofibrils of amyloid beta-protein inhibit specific K+ currents in neocortical cultures | 3 | 4 |
| 138 | 1 | 78 | 138 2003 NEUROCHEMICAL RESEARCH 28(3-4):637-644 Beck M; Bigl V; Rossner S Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo | 0 | 1 |
| 139 | 1 | 56 | 139 2003 NEUROCHEMICAL RESEARCH 28(7):1009-1015 Sant'Angelo A; Trinchese F; Arancio O Usefulness of Behavioral and electrophysiological studies in transgenic models of Alzheimer's disease | 0 | 2 |
| 140 | 2 | 121 | 140 2003 NEUROCHEMICAL RESEARCH 28(11):1683-1691 Klucken J; McLean PJ; Gomez-Tortosa E; Ingelsson M; Hyman BT Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 141 | 3 | 60 | 141 2003 NEUROCHEMICAL RESEARCH 28(11):1705-1713 Selkoe DJ Aging, amyloid, and Alzheimer's disease: A perspective in honor of Carl Cotman | 0 | 0 |
| 142 | 1 | 37 | 142 2003 NEURON 37(4):583-595 Sharon R; Bar-Joseph I; Frosch MP; Walsh DM; Hamilton JA; Selkoe DJ The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease | 5 | 26 |
| 143 | 1 | 50 | 143 2003 NEURON 37(6):911-924 Yang YF; Nishimura I; Imai Y; Takahashi R; Lu BW Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila | 2 | 37 |
| 144 | 2 | 66 | 144 2003 NEURON 37(6):925-937 Kamenetz F; Tomita T; Hsieh H; Seabrook G; Borchelt D; Iwatsubo T; Sisodia S; Malinow R APP processing and synaptic function | 9 | 31 |
| 145 | 4 | 48 | 145 2003 NEURON 39(3):409-421 Oddo S; Caccamo A; Shepherd JD; Murphy MP; Golde TE; Kayed R; Metherate R; Mattson MP; Akbari Y; LaFerla FM Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular A beta and synaptic dysfunction | 6 | 34 |
| 146 | 7 | 41 | 146 2003 NEURON 40(6):1087-1093 Leissring MA; Farris W; Chang AY; Walsh DM; Wu XN; Sun XY; Frosch MP; Selkoe DJ Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death | 1 | 6 |
| 147 | 2 | 20 | 147 2003 NEUROPATHOLOGY 23(1):51-56 Mori H; Tomiyama T; Maeda N; Ozawa K; Wakasa K Lack of amyloid plaque formation in the central nervous system of a patient with Werner syndrome | 0 | 0 |
| 148 | 5 | 402 | 148 2003 NEUROPHARMACOLOGY 45(1):14-44 Dev KK; Hofele K; Barbieri S; Buchman VL; van der Putten H Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease | 1 | 10 |
| 149 | 1 | 29 | 149 2003 NEUROSCIENCE 116(2):511-517 Wang J; Ikonen S; Gurevicius K; Van Groen T; Tanila H Altered auditory-evoked potentials in mice carrying mutated human amyloid presenilin-1 transgenes | 0 | 0 |
| 150 | 3 | 23 | 150 2003 NEUROSCIENCE LETTERS 350(2):113-116 Kanemitsu H; Tomiyama T; Mori H Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 151 | 3 | 114 | 151 2003 NEW ENGLAND JOURNAL OF MEDICINE 349(6):583-596 Merlini G; Bellotti V Molecular mechanisms of amyloidosis | 1 | 20 |
| 152 | 1 | 35 | 152 2003 NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY 77(11):1124-1126 Michikawa M The role of cholesterol in the pathogenesis of Alzheimer's disease | 0 | 0 |
| 153 | 1 | 201 | 153 2003 PHARMACOLOGY & THERAPEUTICS 97(1):35-53 Kitamura Y; Nomura Y Stress proteins and glial functions: possible therapeutic targets for neurodegenerative disorders | 0 | 4 |
| 154 | 2 | 65 | 154 2003 PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES 361(1807):1205-1222 Vendruscolo M; Zurdo J; MacPhee CE; Dobson CM Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systems | 2 | 4 |
| 155 | 5 | 70 | 155 2003 PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES 358(1432):821-828 Rowan MJ; Klyubin I; Cullen WK; Anwyl R Synaptic plasticity in animal models of early Alzheimer's disease | 1 | 4 |
| 156 | 1 | 164 | 156 2003 POLIMERY 48(1):35-43 Jablonowska A; Dadlez M A beta peptide oligomers - potential neurotoxic agents in Alzheimer's disease | 0 | 0 |
| 157 | 3 | 39 | 157 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(1):330-335 Bitan G; Kirkitadze MD; Lomakin A; Vollers SS; Benedek GB; Teplow DB Amyloid beta-protein (A beta) assembly: A beta 40 and A beta 42 oligomerize through distinct pathways | 15 | 27 |
| 158 | 3 | 66 | 158 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(3):1381-1386 Redwine JM; Kosofsky B; Jacobs RE; Games D; Reilly JF; Morrison JH; Young WG; Bloom FE Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis | 1 | 9 |
| 159 | 1 | 48 | 159 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(11):6370-6375 Hoshi M; Sato M; Matsumoto S; Noguchi A; Yasutake K; Yoshida N; Sato K Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3 beta | 3 | 13 |
| 160 | 1 | 52 | 160 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(14):8182-8187 Dickerson TJ; Janda KD Glycation of the amyloid beta-protein by a nicotine metabolite: A fortuitous chemical dynamic between smoking and Alzheimer's disease | 1 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 161 | 4 | 52 | 161 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(18):10417-10422 Gong YS; Chang L; Viola KL; Lacor PN; Lambert MP; Finch CE; Krafft GA; Klein WL Alzheimer's disease-affected brain: Presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss | 13 | 26 |
| 162 | 3 | 290 | 162 2003 PROGRESS IN NEUROBIOLOGY 70(1):1-32 Turner PR; O'Connor K; Tate WP; Abraham WC Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory | 1 | 6 |
| 163 | 4 | 106 | 163 2003 PROGRESS IN NEUROBIOLOGY 71(5):385-400 Sousa MM; Saraiva MJ Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling | 0 | 0 |
| 164 | 1 | 78 | 164 2003 PROTEASES AND THE REGULATION OF BIOLOGICAL PROCESSES 70:163-178 Carrell RW; Huntington JA How serpins change their fold for better and for worse | 0 | 1 |
| 165 | 1 | 50 | 165 2003 PROTEINS-STRUCTURE FUNCTION AND GENETICS 51(1):147-153 Vaiana SM; Palma-Vittorelli MB; Palma MU Time scale of protein aggregation dictated by liquid-liquid demixing | 1 | 6 |
| 166 | 3 | 204 | 166 2003 REVIEWS IN THE NEUROSCIENCES 14(4):317-341 Stein TD; Johnson JA Genetic programming by the proteolytic fragments of the amyloid precursor protein: Somewhere between confusion and clarity | 0 | 0 |
| 167 | 2 | 28 | 167 2003 SCIENCE 299(5607):713-716 Hammarstrom P; Wiseman RL; Powers ET; Kelly JW Prevention of transthyretin amyloid disease by changing protein misfolding energetics | 6 | 42 |
| 168 | 2 | 39 | 168 2003 STROKE 34(2):335-337 Iadecola C; Gorelick PB Converging pathogenic mechanisms in vascular and neurodegenerative dementia | 1 | 10 |
| 169 | 3 | 89 | 169 2003 SWISS MEDICAL WEEKLY 133(19-20):275-282 Johansson J Molecular determinants for amyloid fibril formation: lessons from lung surfactant protein C | 0 | 2 |
| 170 | 1 | 90 | 170 2003 THEORETICAL CHEMISTRY ACCOUNTS 109(1):8-21 Srinivas G; Bagchi B Study of the dynamics of protein folding through minimalistic models | 0 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 171 | 4 | 20 | 171 2003 TRENDS IN MOLECULAR MEDICINE 9(3):85-87 Dodart JC; Bales KR; Paul SM Immunotherapy for Alzheimer's disease: will vaccination work? | 1 | 4 |
| 172 | 1 | 34 | 172 2003 TRENDS IN NEUROSCIENCES 26(1):4-7 Ehlers MD Ubiquitin and synaptic dysfunction: ataxic mice highlight new common themes in neurological disease | 0 | 5 |
| 173 | 1 | 78 | 173 2003 TRENDS IN NEUROSCIENCES 26(4):207-214 Bush AI The metallobiology of Alzheimer's disease | 1 | 31 |
| 174 | 1 | 25 | 174 2003 TRENDS IN NEUROSCIENCES 26(8):407-410 Forman MS; Lee VMY; Trojanowski JQ 'Unfolding' pathways in neurodegenerative disease | 0 | 8 |
| 175 | 3 | 20 | 175 2003 TRENDS IN NEUROSCIENCES 26(10):517-519 Welch K; Yuan JY alpha-synuclein oligomerization: a role for lipids? | 1 | 3 |
| 176 | 4 | 97 | 176 2004 ACTA NEUROBIOLOGIAE EXPERIMENTALIS 64(1):19-31 Zekanowski C; Religa D; Graff C; Filipek S; Kuznicki J Genetic aspects of Alzheimer's disease | 0 | 2 |
| 177 | 9 | 93 | 177 2004 ACTA NEUROBIOLOGIAE EXPERIMENTALIS 64(1):71-79 Koudinov AR; Berezov TT Alzheimer's amyloid-beta (A beta) is an essential synaptic protein, not neurotoxic junk | 0 | 0 |
| 178 | 1 | 40 | 178 2004 ACTA NEUROBIOLOGIAE EXPERIMENTALIS 64(1):99-105 Kihara T; Shimohama S Alzheimer's disease and acetylcholine receptors | 0 | 0 |
| 179 | 2 | 57 | 179 2004 ACTA NEUROPATHOLOGICA 107(5):389-398 Maat-Schieman MLC; Yamaguchi H; Hegeman-Kleinn IM; Welling-Graafland C; Natte R; Roos RAC; van Duinen SG Glial reactions and the clearance of amyloid beta protein in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type | 0 | 0 |
| 180 | 2 | 92 | 180 2004 ANNALS OF INTERNAL MEDICINE 140(8):627-638 Selkoe DJ Alzheimer disease: Mechanistic understanding predicts novel therapies | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 181 | 1 | 14 | 181 2004 ANNALS OF NEUROLOGY 55(3):303-305 Jagust W The proteomics of positron emission tomography | 0 | 0 |
| 182 | 3 | 69 | 182 2004 ANNALS OF NEUROLOGY 55(6):801-814 Trinchese F; Liu SM; Battaglia F; Walter S; Mathews PM; Arancio O Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice | 0 | 0 |
| 183 | 9 | 88 | 183 2004 BIOCHEMISTRY 43(23):7365-7381 Hurshman AR; White JT; Powers ET; Kelly JW Transthyretin aggregation under partially denaturing conditions is a downhill polymerization | 0 | 0 |
| 184 | 3 | 30 | 184 2004 BIOPHYSICAL JOURNAL 86(6):3585-3597 Mobley DL; Cox DL; Singh RRP; Maddox MW; Longo ML Modeling amyloid beta-peptide insertion into lipid bilayers | 0 | 0 |
| 185 | 5 | 86 | 185 2004 BIOPOLYMERS 76(1):4-14 Bateman DA; Chakrabartty A Interactions of Alzheimer amyloid peptides with cultured cells and brain tissue, and their biological consequences | 0 | 0 |
| 186 | 1 | 50 | 186 2004 BRAIN 127:73-88 Jonsson PA; Ernhill K; Andersen PM; Bergemalm D; Brannstrom T; Gredal O; Nilsson P; Marklund SL Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis | 0 | 3 |
| 187 | 1 | 53 | 187 2004 BRAIN RESEARCH 998(1):73-82 Kasa P; Papp H; Kasa P; Pakaski M; Balaspiri L Effects of amyloid-beta on cholinergic and acetylcholinesterase-positive cells in cultured basal forebrain neurons of embryonic rat brain | 0 | 0 |
| 188 | 2 | 58 | 188 2004 BRAIN RESEARCH 1000(1-2):1-7 Butterfield DA Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain | 0 | 2 |
| 189 | 3 | 103 | 189 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61(3):326-335 Johansson J; Weaver TE; Tjernberg LO Proteolytic generation and aggregation of peptides from transmembrane regions: lung surfactant protein C and amyloid beta-peptide | 0 | 1 |
| 190 | 6 | 278 | 190 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61(14):1729-1750 Bonifati V; Oostra BA; Heutink P Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 191 | 3 | 116 | 191 2004 CURRENT MEDICINAL CHEMISTRY 11(4):491-499 Chow MKM; Lomas DA; Bottomley SP Promiscuous beta-strand interactions and the conformational diseases | 0 | 2 |
| 192 | 11 | 58 | 192 2004 EUROPEAN JOURNAL OF NEUROSCIENCE 19(10):2839-2846 Klyubin I; Walsh DM; Cullen WK; Fadeeva JV; Anwyl R; Selkoe DJ; Rowan MJ Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo | 0 | 0 |
| 193 | 1 | 79 | 193 2004 EXPERIMENTAL NEUROLOGY 188(2):224-237 Wen PH; Hof PR; Chen XP; Gluck K; Austin G; Younkin SG; Younkin LH; DeGasperi R; Sosa MAG; Robakis NK; Haroutunian V; Elder GA The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice | 0 | 0 |
| 194 | 5 | 42 | 194 2004 FASEB JOURNAL 18(10) Barnham KJ; Haeffner F; Ciccotosto GD; Curtain CC; Tew D; Mavros C; Beyreuther K; Carrington D; Masters CL; Cherny RA; Cappai R; Bush AI Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid | 0 | 0 |
| 195 | 2 | 21 | 195 2004 HISTOLOGY AND HISTOPATHOLOGY 19(3):845-852 Fukuchi K; Hart M; Yan Z; Hassell JR; Li L Transgenic mice overexpressing both amyloid B-protein and perlecan in pancreatic acinar cells | 0 | 0 |
| 196 | 1 | 61 | 196 2004 INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 36(10):2066-2076 Clementi ME; Martorana GE; Pezzotti M; Giardina B; Misiti F Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell | 0 | 0 |
| 197 | 1 | 40 | 197 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(13):12206-12212 Green JD; Goldsbury C; Kistler J; Cooper GJS; Aebi U Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation | 0 | 0 |
| 198 | 3 | 73 | 198 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(13):13183-13189 Sirangelo I; Malmo C; Iannuzzi C; Mezzogiorno A; Bianco MR; Papa M; Irace G Fibrillogenesis and cytotoxic activity of the amyloid-forming apomyoglobin mutant W7FW14F | 0 | 0 |
| 199 | 3 | 56 | 199 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(14):14111-14119 Plakoutsi G; Taddei N; Stefani M; Chiti F Aggregation of the acylphosphatase from Sulfolobus solfataricus - The folded and partially unfolded states can both be precursors for amyloid formation | 0 | 0 |
| 200 | 1 | 53 | 200 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(15):14673-14678 Nagano S; Huang XD; Moir RD; Payton SM; Tanzi RE; Bush AI Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (A beta) and generates A beta-COX-2 hetero-oligomers that are increased in Alzheimer's disease | 0 | 0 |
Page 2: 1 (1) 2 (101) 3 (201)
Generated by: HistCite(Vlad).
Version: 2004.08.24